SCHEMBL23047342

SCHEMBL23047342

CNC(=O)c1ccc(C(=N)c2c(N)ncnc2Nc2ccc(NC=O)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 4/20 0.41
PTK2 Q05397 5/20 0.40
MKNK2 Q9HBH9 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TTBK1 Q5TCY1 1/20 0.36
TTBK2 Q6IQ55 1/20 0.36
EGFR P00533 2/20 0.35
AURKB Q96GD4 1/20 0.35
INCENP Q9NQS7 1/20 0.35
JAK2 O60674 1/20 0.35
KLK7 P49862 1/20 0.35
KLK14 Q9P0G3 1/20 0.35
SYK P43405 1/20 0.35
ERBB2 P04626 1/20 0.35
CARM1 Q86X55 1/20 0.34
KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23047341 0.85 PRMT1 (0.42) PRMT1TTBK1TTBK2EGFRAURKB
SCHEMBL20878857 0.85 PRMT1 (0.41) PRMT1TTBK1TTBK2EGFRERBB2
SCHEMBL23047328 0.85 EGFR (0.44) PRMT1MEN1KMT2ATTBK1TTBK2
SCHEMBL19683621 0.83 PRMT1 (0.44) PRMT1TTBK1TTBK2EGFRERBB2
SCHEMBL19683616 0.82 PRMT1 (0.43) PRMT1TTBK1TTBK2EGFRERBB2
SCHEMBL20878945 0.80 EIF2AK2 (0.42) SYKERBB2
SCHEMBL20878934 0.80 PRMT1 (0.37) PRMT1EGFRERBB2CARM1
SCHEMBL24671954 0.80 SRC (0.40) PRMT1CARM1
SCHEMBL20878943 0.79 HPGD (0.44) RXFP1KMT2AEGFRJAK2SYK
SCHEMBL23047326 0.79 PRMT1 (0.39) PRMT1TTBK1TTBK2EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3466952-B1 1-(4-(4-AMINO-3-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)-PHENYL)-UREA DERIVATIVES AS FLT3 KINASE INHIBITORS FOR TREATING CANCER PRECEDO PHARMACEUTICALS CO LTD (CN) 2021-03-03 EP disclosed